More money moves into growth area of radiopharmaceuticals

Boston, USA-based Ratio Therapeutics has completed a $50 million series B financing, bringing the total raised by the company so far to over $90 million.

There were fresh contributions from long-time investors Schusterman and Duquesne, as well as new money from Bristol Myers Squibb (NYSE: BMY) and the Center for Technology Licensing at Cornell University.

With pharma majors, notably Novartis (NOVN: VX), making  significant investments in radiopharmaceuticals, a large number of start-ups have also begun innovating in the space in recent years.